Decreased LDL cholesterol concentration
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Increased HDL cholesterol concentration
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
APOLIPOPROTEIN C-III, NONGLYCOSYLATED PHENOTYPE
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Amyloidosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
694
|
93
|
0.310 |
moderate |
< 0.001 |
1 |
|
2016 |
2016 |
Celiac Disease
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
527
|
263
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hypercholesterolemia, Familial
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
1423
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hyperlipoproteinemia Type IIb
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
25
|
16
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Morbilliform Drug Reaction
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hyperlipoproteinemias
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
49
|
7
|
0.300 |
None |
1.000 |
1 |
|
1991 |
1991 |
Hyperlipoproteinemia Type IIa
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
201
|
661
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
613
|
283
|
0.200 |
None |
1.000 |
1 |
|
1993 |
1993 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hyperthyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
279
|
27
|
0.200 |
None |
1.000 |
1 |
|
1993 |
1993 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.200 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hypotriglyceridemia
|
disease |
|
Disease or Syndrome
|
9
|
2
|
0.110 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Phosphatidylinositol measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
816
|
176
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatitis C, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
430
|
80
|
0.010 |
None |
1.000 |
1 |
2
|
2013 |
2013 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |